Low-Dose Aspirin for Cardiovascular Prevention in Giant Cell Arteritis

17 Apr 20264 min read0 viewsJournal Feed

GIST

Rheumatology

Clinical Editorial

Summary

JAMA Network Open published a clinical update in Research Highlights on 17 Apr 2026. The item focuses on Low-Dose Aspirin for Cardiovascular Prevention in Giant Cell Arteritis. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

BMJ OpenRelated by Drugaspirin

Knowledge and attitudes towards perioperative pulmonary embolism in major orthopaedic surgery patients: a cross-sectional study in Shanghai

Research Highlights • 14 May 2026

PLOS ONERelated by Drugaspirin

Physicochemical, spectral, medicinal, and toxicological studies of Ketoprofen, Ibuprofen, and their major degradants: A quantum-chemical and in silico approach

Research Highlights • 06 May 2026

BMJ OpenRelated by Drugaspirin

Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA

Research Highlights • 27 Apr 2026

Med News TodayRelated by Drugaspirin

Study Finds Lacunar Stroke Linked to Small Vessel Disease, Not Large Artery Blockage

Research Highlights • 09 May 2026

Med News TodayRelated by Drugaspirin

New Blood-Thinning Drug Reduces Second Stroke Risk Without Bleeding Increase

Research Highlights • 27 Apr 2026

PLOS MedRelated by Drugaspirin

Early Aspirin Withdrawal vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention:

Research Highlights • 26 Mar 2026

Feed Metadata

Source

JAMA Network Open